Marshall Wace, LLP Medi Wound Ltd. Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.38 - $5.71 $34,256 - $57,870	-10,135 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.77 - $6.05 $38,208 - $61,316	10,135 New	10,135 $54,000
Q2 2019 Aug 14, 2019	SELL	$3.0 - $5.5 $55,983 - $102,635	-18,661 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$4.24 - $5.24 $79,122 - $97,783	18,661 New	18,661 $93,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $789M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.